SEC Filings

Filing date Form Description Filing Group View
DRS/A

mendment to a previously filed DRS
Registration Statements
 View HTML
0001104659-22-118284.pdf
0001104659-22-118284.rtf
0001104659-22-118284.xls
DRSLTR

Correspondence Related to Draft Registration Statement

 View HTML
0001104659-22-118287.pdf
0001104659-22-118287.rtf
0001104659-22-118287.xls
UPLOAD

UPLOAD
Other
 View HTML
0000000000-22-011842.pdf
0000000000-22-011842.rtf
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Registration Statements
 View HTML
0001104659-22-104874.pdf
0001104659-22-104874.rtf
0001104659-22-104874.xls
DRSLTR

Correspondence Related to Draft Registration Statement

 View HTML
0001104659-22-104875.pdf
0001104659-22-104875.rtf
425

Filing of certain prospectuses and communications in connection with business combination transactions
Other
 View HTML
0001104659-22-104163.pdf
0001104659-22-104163.rtf
0001104659-22-104163.xls
Displaying 51 - 56 of 56 results

Data provided by Kaleidoscope.

Print Page
Email Alerts
RSS Feeds
Contact IR
Site Map Terms of Use Privacy

Contact Info

YS Biopharma Co., Ltd.

11 Firstfield Road Suite A
Gaithersburg, Maryland 20878 USA

Tel: +1 (301) 208 8823
Fax: +1 (301) 208 8827

bjinfo@yishengbio.com